Phase III

Here is a list of phase III trials that the Medelis team has completed.

Study Indication Sites Patients Services* Countries
Phase III Lung transplantation

21

240

Full service Australia, Austria, United States
Phase III Non-small cell lung cancer (Stage IIIb/IV) – first line

103

1,200

Clinical data review/SAE narratives United States
Phase III Non-small cell lung cancer (Stage IIIb/IV) – second line

140

900

Clinical data review/SAE narratives United States
Phase III Chronic myelogenous leukemia

103

642

Clinical data review United States
Phase III Chronic myelogenous leukemia –chronic phase

140

771

Independent, unblinded clinical data review United States
Phase III Unresectable or metastatic GIST

121

736

Independent, unblinded clinical data review United States
Phase IIIB Dental device

8

60

Full Service United States
European Operations
Phase III Breast cancer

4

16

Full service UK
Phase III Melanoma

1

35

Full service UK
Phase III Colorectal

21

363

Full service UK, Poland, Denmark
Phase III Colorectal

10

60

Full service UK, Poland, Denmark
Phase III Non-small cell lung cancer

5

50

Full service UK
Phase III Gliomas

30

150

Full service UK, Denmark, France, Germany
Phase III Hematological Malignancies

4

40

Full service Sweden, UK
Phase III Head & Neck Cancer

25

500

Full Service UK, Germany, France

If you’d to talk to us about our experience or your study, contact us.